Skip to main content
. 2017 Oct 17;12:7669–7680. doi: 10.2147/IJN.S141920

Figure 4.

Figure 4

The effect of vorinostat and released vorinostat against HuCC-T1 and SNU478 cells.

Notes: (A) Anticancer activity and (B) apoptosis/necrosis analysis. The supernatants were taken at 1 day, 3 days, 5 days, and 7 days of release experiment as described in experimental section. These solutions were used for released vorinostat treatment.

Abbreviation: PI, propidium iodide.